A carregar...
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Recent developments have set the stage for immunotherapy as a supplement to conventional cancer treatment. Consequently, a significant effort is required to further improve efficacy and specificity, particularly the identification of optimal therapeutic targets for clinical testing. Cancer/testis an...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599236/ https://ncbi.nlm.nih.gov/pubmed/26158218 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|